send to a friend by email
2019-02-17
According to the financial statements of Birzeit Pharmaceuticals BPC for the year 2018, Net profit after tax of the period reached 7,967,506 USD Compared with Net profit after tax 11,016,069 USD for 2017, a net decrease in profit of 27.67%.Total assets of the company reached 90,017,331 USD compared with total assets of 80,644,765 USD at the end of year 2017, a net increase of 11.62%.Total liabilities of the company reached 17,553,370 USD compared with total liabilities of 12,133,373 USD at the end of year 2017, a net increase of 44.67%. Net ownership equity of the company reached 72,463,961 USD (Including Non-Controlling Interests of 585,650 USD) compared with total owner equity of 68,511,392 USD (Including Non-Controlling Interests of 521,788 USD) at the end of year 2017, a net increase of 5.77%.Noting that paid-in capital increased from 18,502,825 USD in year 2017 to 19,002,401 USD of this year,a net increase of 2.70%
|
|